Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rho guanine nucleotide exchange factor 7 (ARHGEF7), commonly referred to as Beta-PIX or COOL-1, is a multidomain protein that functions as a specific guanine nucleotide exchange factor for the Rho-family GTPases Rac1 and Cdc42 (UniProt: Q14155). By facilitating the transition of these GTPases from an inactive GDP-bound state to an active GTP-bound state, ARHGEF7 plays a pivotal role in regulating actin cytoskeleton remodeling, focal adhesion dynamics, and cellular morphology (PubMed: 25659585). In clinical oncology, ARHGEF7 is frequently overexpressed in various malignancies, such as glioblastoma and breast cancer, where it promotes tumor cell proliferation, invasion, and metastasis (PubMed: 30217959). Targeting the ARHGEF7 mRNA through RNA interference (RNAi) or antisense oligonucleotides is an active area of research aimed at downregulating protein expression to inhibit these oncogenic processes. Beyond its role in cancer, ARHGEF7 is essential for neuronal development and synaptic plasticity, and its dysfunction has been linked to neurodevelopmental disorders (NCBI Gene: 8874). Consequently, therapeutic strategies must carefully address the potential for off-target effects and the disruption of normal physiological functions mediated by this protein.
RNA interference (RNAi) mediated degradation of mRNA leading to decreased protein synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rho guanine nucleotide exchange factor 7 (ARHGEF7) (ARHGEF7).